These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 29331573)

  • 61. Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations.
    Abe T; Tamaki T; Makino S; Ebara T; Hirai R; Miyaura K; Kumazaki Y; Ohno T; Shikama N; Nakano T; Kato S
    Radiat Oncol; 2014 Dec; 9():293. PubMed ID: 25526986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy.
    Dolezel M; Odrazka K; Vanasek J; Kohlova T; Kroulik T; Kudelka K; Spitzer D; Mrklovsky M; Tichy M; Zizka J; Jalcova L
    Br J Radiol; 2011 Sep; 84(1005):850-6. PubMed ID: 21849368
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Automatic segmentation of magnetic resonance images for high-dose-rate cervical cancer brachytherapy using deep learning.
    Yoganathan SA; Paul SN; Paloor S; Torfeh T; Chandramouli SH; Hammoud R; Al-Hammadi N
    Med Phys; 2022 Mar; 49(3):1571-1584. PubMed ID: 35094405
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of auto-segmentation for brachytherapy of postoperative cervical cancer using deep learning-based workflow.
    Wang J; Chen Y; Tu Y; Xie H; Chen Y; Luo L; Zhou P; Tang Q
    Phys Med Biol; 2023 Feb; 68(5):. PubMed ID: 36753762
    [No Abstract]   [Full Text] [Related]  

  • 65. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
    Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
    Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
    J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mapping of dose distribution from IMRT onto MRI-guided high dose rate brachytherapy using deformable image registration for cervical cancer treatments: preliminary study with commercially available software.
    Kim H; Huq MS; Houser C; Beriwal S; Michalski D
    J Contemp Brachytherapy; 2014 Jun; 6(2):178-84. PubMed ID: 25097559
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
    Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
    Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ureter dose optimization during image guided brachytherapy for cervical cancer.
    Sarwar A; Lalli N; Eminowicz G
    Brachytherapy; 2022; 21(4):397-404. PubMed ID: 35422401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
    Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
    Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
    Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
    Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
    Thiruthaneeswaran N; Groom N; Lowe G; Bryant L; Hoskin PJ
    Brachytherapy; 2018; 17(1):181-186. PubMed ID: 29153466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration.
    Thörnqvist S; Petersen JB; Høyer M; Bentzen LN; Muren LP
    Acta Oncol; 2010 Oct; 49(7):1023-32. PubMed ID: 20831491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
    Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
    Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.